BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.325
0.00 (0.00%)
Pre-Market: 08:51
BioLine Rx Debt to Equity Ratio: 2.106 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.106 |
| March 31, 2024 | 0.7364 |
| December 31, 2023 | 0.7391 |
| September 30, 2023 | 0.8783 |
| June 30, 2023 | 0.5497 |
| March 31, 2023 | 0.2761 |
| December 31, 2022 | 0.20 |
| September 30, 2022 | 0.1649 |
| June 30, 2022 | 0.0179 |
| March 31, 2022 | 0.03 |
| December 31, 2021 | 0.0405 |
| September 30, 2021 | 0.0504 |
| June 30, 2021 | 0.059 |
| March 31, 2021 | 0.0791 |
| December 31, 2020 | 0.2647 |
| September 30, 2020 | 0.2629 |
| June 30, 2020 | 0.2462 |
| March 31, 2020 | 0.2755 |
| December 31, 2019 | 0.2544 |
| September 30, 2019 | 0.2341 |
| June 30, 2019 | 0.2149 |
| March 31, 2019 | 0.1932 |
| December 31, 2018 | 0.2113 |
| September 30, 2018 | 0.0044 |
| June 30, 2018 | 0.0044 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.0046 |
| December 31, 2017 | 0.0047 |
| September 30, 2017 | 0.0046 |
| June 30, 2017 | 0.0052 |
| March 31, 2017 | 0.009 |
| December 31, 2016 | 0.0098 |
| September 30, 2016 | 0.0095 |
| June 30, 2016 | 0.0091 |
| March 31, 2016 | 0.009 |
| December 31, 2015 | 0.0092 |
| September 30, 2015 | 0.0091 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0007 |
| December 31, 2012 | 0.0024 |
| September 30, 2012 | 0.0024 |
| June 30, 2012 | 0.0027 |
| March 31, 2012 | 0.0032 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0179
Minimum
Jun 2022
2.106
Maximum
Jun 2024
0.3806
Average
0.2544
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Compugen Ltd | 0.00 |
| Pluri Inc | -4.801 |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | 0.00 |
| BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 64.60M |
| Total Liabilities (Quarterly) | 50.62M |
| Shareholders Equity (Quarterly) | 13.98M |
| Current Ratio | 1.609 |
| Net Debt Paydown Yield | -8.19% |